Vision Cares about Human Clear Sight

Vision Eye Institute Limited (hereinafter referred to as Vision), founded in 2001 and acquired by Jangho Group Company Limited in 2015 (hereinafter referred to as Jangho), is the largest Australian eye hospital provider, playing a leading role in global chain eye care service institutes with a distinguished medical brand. With world first-class quality and risk management systems, Vision has 14 professional eye chain clinics, 9 advanced day surgery hospitals and 6 laser eye surgery centers in Australia.  As long ago as 1991, the ophthalmologists of Vision acted as the pioneers in the field of Australian vision correction surgeries, and in 2011, successfully performed the first case of laser cataract surgery in the southern hemisphere, leading the way for the technology in Austral. In 2004, Vision listed on the ASX with stock code VGH, later changed to VEI, and in 2015, Jangho fully acquired Vision who, nowadays, is a vanguard accompanying with Jangho’s march into the health care field. Vision delisted from the ASX on December 15, 2015.


Vision, concentrating on high-tech eye treatments and surgeries, was credited as the “Great Master” in the field of ophthalmology since it could provide a broad range of professional eye care, including cataract surgery, corneal transplant surgery, retinal surgery, intravitreal injection and laser treatment, etc.


Since founded, Vision has been at the forefront of ophthalmic technology. When medical trials are required, Vision doctors are inevitably the default choice in the country.   Specialists of Vision are usually invited to participate in the international academic conferences and made keynote speeches, also have been providing articles to most prestigious magazines, and hundreds of their articles appear in teaching materials and global high-end scientific documents.

Over the past 20 years, ophthalmologists of Vision have been committed to pioneering and advancing the technologies in the field of world ophthalmic medical care, including the first application of phacoemulsification in the cataract surgery, first carrying out CMICS and first performing laser cataract surgery of Southern hemisphere.